Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 19026 - 19050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	PIM1	5292	upregulated	[Organoselenium Compounds binds to Copper] which results in increased expression of PIM1 mRNA	6p21.2	A21751
Copper	Approved Investigational	PIN4P1	728758	downregulated	[Disulfiram binds to Copper] which results in decreased expression of PIN4P1 mRNA	15q15.3	A21750
Copper	Approved Investigational	PIP4K2A	5305	downregulated	[Disulfiram binds to Copper] which results in decreased expression of PIP4K2A mRNA	10p12.2	A21750
Copper	Approved Investigational	PIR	8544	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PIR mRNA	Xp22.2	A21749
Copper	Approved Investigational	PITPNM3	83394	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PITPNM3 mRNA	17p13.2-p13.1	A21749
Copper	Approved Investigational	PIWIL4	143689	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PIWIL4 mRNA	11q21	A21749
Copper	Approved Investigational	PKDCC	91461	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PKDCC mRNA	2p21	A21749
Copper	Approved Investigational	PLA2G7	7941	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PLA2G7 mRNA	6p12.3	A21749
Copper	Approved Investigational	PLAC8L1	153770	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PLAC8L1 mRNA	5q32	A21749
Copper	Approved Investigational	PLCL2	23228	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PLCL2 mRNA	3p24.3	A21749
Copper	Approved Investigational	PLCXD2	257068	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PLCXD2 mRNA	3q13.2	A21749
Copper	Approved Investigational	PLCXD3	345557	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PLCXD3 mRNA	5p13.1	A21749
Copper	Approved Investigational	PLEKHG3	26030	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PLEKHG3 mRNA	14q23.3	A21749
Copper	Approved Investigational	PLIN2	123	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PLIN2 mRNA	9p22.1	A21749
Copper	Approved Investigational	PLIN4	729359	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PLIN4 mRNA	19p13.3	A21749
Copper	Approved Investigational	PLK1	5347	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PLK1 mRNA	16p12.2	A21749
Copper	Approved Investigational	PLOD2	5352	upregulated	[Disulfiram binds to Copper] which results in increased expression of PLOD2 mRNA	3q24	A21750
Copper	Approved Investigational	PLOD2	5352	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PLOD2 mRNA	3q24	A21749
Copper	Approved Investigational	PLPP5	84513	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PLPP5 mRNA	8p11.23	A21749
Copper	Approved Investigational	PLPPR5	163404	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PLPPR5 mRNA	1p21.3	A21749
Copper	Approved Investigational	PLSCR4	57088	upregulated	[Disulfiram binds to Copper] which results in increased expression of PLSCR4 mRNA	3q24	A21750
Copper	Approved Investigational	PLSCR4	57088	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PLSCR4 mRNA	3q24	A21749
Copper	Approved Investigational	PLXNB2	23654	upregulated	[Disulfiram binds to Copper] which results in increased expression of PLXNB2 mRNA	22q13.33	A21750
Copper	Approved Investigational	PM20D2	135293	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PM20D2 mRNA	6q15	A21749
Copper	Approved Investigational	PNLDC1	154197	downregulated	[Disulfiram binds to Copper] which results in decreased expression of PNLDC1 mRNA	6q25.3	A21750

Displaying entries 19026 - 19050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability